IP Didi Pharmaceutical Import Profile — Kazakhstan (DGFT 2022–2026)

Name: IP Didi Pharmaceutical Import Records from India — 5 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

IP Didi — Pharmaceutical Importer Profile (2026) | 5 Products, $1.3M Trade | TransData Nexus

IP Didi

Pharmaceutical Importer · Kazakhstan · Ayurvedic & Herbal Products Focus · $1.3M Total Trade · DGFT Verified

IP Didi is a pharmaceutical importer based in Kazakhstan with a total trade value of $1.3M across 5 products in 2 therapeutic categories. Based on 5,124 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. IP Didi sources from 14 verified Indian suppliers, with Jangir Exports accounting for 38.8% of imports.

IP Didi — Import Portfolio & Supplier Network

IP Didi import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to IP Didi?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Jangir Exports	$1.7M	1,633	38.8%
Sacred Leaves Private Limited	$731.9K	4,095	16.9%
Gurbani Exports	$504.1K	1,500

What Formulations Does IP Didi Import?

Formulation	Value	Ships
Ayurvedic/herbal- neem TAB 60	$84.7K	8
Ayurvedic/herbal- triphala TAB 60	$79.6K	20
Ayurvedic/herbal items-	$60.0K	33
Ayurvedic/herbal- speman TAB 60	$59.3K	10
Ayurvedic/herbal- liv 52 ds TAB 60	$54.1K	7
Ayurvedic/herbal- rhuematil gel 30 GM	$51.6K	2
Herbal and pharmaceuticals products-	$49.0K	669
Herbal article / ods / product / item as per attached invoiceno. ex-sl0120/23-24	$46.0K	1
Ayurvedic/herbal- liv 52 TAB 100	$41.4K	4
Herbal article / ods / product / item as per attached invoiceno. ex-sl0199/23-24 dated	$39.8K	1
Ayurvedic/herbal- ashwagangha TAB 60	$38.8K	6
Herbal products (as per attached invoiceno. ex-sl0239/23-24, dated	$32.3K	1
Ayurvedic/herbal- evacare CAPS 30	$25.9K	2
Herbal article / ods / product / item as per attached invoiceno. ex-sl0166/23-24	$23.4K	1
Ayurvedic/herbal trishun TAB	$23.2K	4

IP Didi imports 6,077 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Herbal	Ayurvedic & Herbal Products	$697.8K	3,241	3.7%	4
2	Ayurvedic	Ayurvedic & Herbal Products	$620.9K	1,764	2.7%	9
3	Kwatha	Ayurvedic & Herbal Products	$19.0K	94	3.6%	8
4	Ledipasvir	Antiviral & HIV Medications	$8.4K	9	0.7%	5
5	Gutika	Ayurvedic & Herbal Products	$3.8K	16	3.0%	7

IP Didi imports 5 pharmaceutical products across 2 categories into Kazakhstan totaling $1.3M.

IP Didi — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

IP Didi is a pharmaceutical importer and buyer based in Kazakhstan, specializing in the acquisition of finished pharmaceutical formulations from India. The company has been active in the importation of various pharmaceutical products, focusing primarily on herbal and Ayurvedic medicines. While specific details about its headquarters and parent company are not publicly disclosed, IP Didi plays a significant role in the distribution of these products within Kazakhstan. The company's operations are integral to the pharmaceutical supply chain, ensuring the availability of a diverse range of medicines to meet the healthcare needs of the Kazakhstani population.

2Distribution Network

Specific information regarding IP Didi's warehouse locations and logistics capabilities is not publicly available. However, given the scale of its operations, including over 5,000 shipments from India, it is likely that the company has established a robust distribution network within Kazakhstan. This network would encompass strategic warehouse locations and efficient logistics systems to facilitate the timely delivery of pharmaceutical products across the country. The company's geographic coverage is expected to be extensive, ensuring that both urban and rural areas have access to the imported medicines.

3Industry Role

IP Didi functions as a primary wholesaler in Kazakhstan's pharmaceutical supply chain. By importing a wide array of finished pharmaceutical formulations from India, the company acts as a crucial intermediary between Indian manufacturers and the Kazakhstani market. Its role involves sourcing, importing, and distributing pharmaceutical products, thereby ensuring a steady supply of medicines to various healthcare providers, including hospitals, clinics, and pharmacies across Kazakhstan.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — IP Didi

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

IP Didi's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of its imports. This indicates a strategic focus on specific therapeutic areas, particularly herbal and Ayurvedic products. The company's reliance on a limited number of products suggests a deliberate approach to cater to a niche market segment within Kazakhstan. However, this concentration also implies potential risks, such as vulnerability to supply chain disruptions or changes in market demand for these specific products. The stability of IP Didi's relationships with its Indian suppliers, including Jangir Exports and Sacred Leaves Private Limited, is crucial to mitigate these risks.

2Supply Chain Resilience

The resilience of IP Didi's supply chain is closely tied to its relationships with Indian suppliers. The company's significant import volumes from suppliers like Jangir Exports and Sacred Leaves Private Limited suggest established and stable partnerships. However, the lack of publicly available information on backup suppliers and the diversity of formulations imported raises concerns about the company's preparedness for potential supply chain disruptions. To enhance resilience, IP Didi may consider diversifying its supplier base and increasing the variety of formulations imported, thereby reducing dependency on a limited number of sources.

Importing Pharmaceuticals into Kazakhstan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kazakhstan

1Regulatory Authority & Framework

The primary regulatory authority overseeing pharmaceutical imports in Kazakhstan is the Ministry of Health. Key legislation governing pharma imports includes the Health Code of the Republic of Kazakhstan, which outlines the requirements for the importation, registration, and distribution of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining registration from the Ministry of Health, which requires submission of a comprehensive dossier demonstrating the product's quality, safety, and efficacy. This process ensures that imported medicines meet the standards set by Kazakhstani authorities.

2Import Licensing & GMP

Import licensing in Kazakhstan is mandatory for the importation of pharmaceutical products. Importers must obtain a license from the Ministry of Health, which involves submitting an application along with necessary documentation, including certificates of analysis and Good Manufacturing Practice (GMP) certificates. Kazakhstan recognizes GMP certificates from the European Union, World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must also hold wholesale distribution authorization to legally distribute medicines within the country.

Quality & Labeling

IP Didi — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

IP Didi's focus on herbal and Ayurvedic products reflects a strategic decision to cater to the growing demand for traditional and natural medicines in Kazakhstan. Market demand is driven by consumer preferences for alternative therapies and the cultural significance of these products. The company's importation of Ayurvedic products, such as Prabhakar Vati, indicates an understanding of the therapeutic needs and preferences of the Kazakhstani market. This product strategy positions IP Didi to serve a niche segment seeking natural and holistic treatment options.

2Sourcing Profile

IP Didi's sourcing strategy is centered on importing generic drugs, particularly those in the herbal and Ayurvedic categories. The company's preference for formulations like Prabhakar Vati suggests a focus on traditional medicines with established efficacy. India's well-developed pharmaceutical industry, with its expertise in producing high-quality generic medicines, aligns with IP Didi's procurement needs. This sourcing approach enables the company to offer cost-effective and culturally relevant products to the Kazakhstani market.

3Market Positioning

Seller's Guide — How to Become a Supplier to IP Didi

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with IP Didi, particularly those specializing in herbal and Ayurvedic products. Gaps in IP Didi's current sourcing may include a limited variety of formulations or specific product types not currently imported. Indian exporters can explore these gaps by offering products that complement IP Didi's existing portfolio, thereby enhancing the company's product range and meeting the diverse needs of the Kazakhstani market.

2Requirements & Qualifications

Indian exporters seeking to supply IP Didi and the Kazakhstan market must ensure that their products comply with Kazakhstani regulatory standards. This includes obtaining GMP certificates recognized by Kazakhstan, such as those from the EU, WHO, or PIC/S. Products must also meet quality standards, including batch testing and stability requirements. Labeling must be in Kazakh and Russian, providing all necessary information as per regulatory guidelines.

3How to Approach

Frequently Asked Questions — IP Didi

What products does IP Didi import from India?

IP Didi imports 5 pharmaceutical products across 2 categories. Top imports: Herbal ($697.8K), Ayurvedic ($620.9K), Kwatha ($19.0K), Ledipasvir ($8.4K), Gutika ($3.8K).

Who supplies pharmaceuticals to IP Didi from India?

IP Didi sources from 14 verified Indian suppliers. The primary supplier is Jangir Exports (38.8% of imports, $1.7M).

What is IP Didi's total pharmaceutical import value?

IP Didi's total pharmaceutical import value from India is $1.3M, based on 5,124 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does IP Didi focus on?

IP Didi imports across 2 categories. The largest: Ayurvedic & Herbal Products (99.4%), Antiviral & HIV Medications (0.6%).

Get Full IP Didi Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.